The Role of Circadian Clock Proteins in Innate and Adaptive Immunity — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

The Role of Circadian Clock Proteins in Innate and Adaptive Immunity — Stella

Home/Pneumonia/

View on ClinicalTrials.gov

Recruiting

Back to Pneumonia trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Barnes Jewish Hospital, St Louis, Missouri

Key details

Sponsor

Washington University School of Medicine

Collaborators

National Institute of General Medical Sciences (NIGMS)

Enrollment target

~144 participants

Started

October 2024

Primary completion

July 2026

Age range

18 Years – 65 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.